# Semaglutide and Cognition in Healthy Volunteers

> **NCT06363487** · NA · COMPLETED · sponsor: **University of Oxford** · enrollment: 70 (actual)

## Conditions studied

- Cognitive Change

## Interventions

- **DRUG:** Semaglutide, 0.5 mg/mL
- **OTHER:** Placebo, 0.9% NaCl 1.5mL

## Key facts

- **NCT ID:** NCT06363487
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-06
- **Primary completion:** 2024-12-11
- **Final completion:** 2024-12-11
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2025-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06363487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06363487, "Semaglutide and Cognition in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06363487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*